![]() |
|
|
Vol. 30, Issue 3, 254-261, March 2002
Department of Psychology, Rutgers, The State University of New
Jersey, Piscataway, New Jersey
We investigated the pharmacokinetic determinants of the frequency
of intravenous cocaine self-administration in 2.5-h sessions. Two
groups of rats were implanted with dual catheters that permitted cocaine infusion and blood sampling via the femoral and jugular vein
catheters, respectively. Half of the animals in each group self-administered one of the two cocaine unit doses (0.5 and 1 mg/kg/infusion) by pressing a lever under a continuous schedule of
reinforcement. To monitor serum cocaine concentrations, the remaining
animals received concurrent, response-independent infusions whenever
the matched animals self-administered cocaine infusions. Multiple
concentration-time data in two successive self-administrations were
determined to monitor the extent of fluctuation in concentrations by
pharmacokinetic modeling. Behavioral analyses revealed the higher unit
dose (1 mg/kg) resulted in less frequent cocaine self-administration, and a longer interinfusion interval, whereas the total doses were similar for the two groups (24.5-27.0 mg/kg/2.5 h). Cocaine decayed biexponentially. Both the values of clearance and terminal
elimination rate constant for the self-administration paradigm were
significantly greater than those after the bolus cocaine dosing series
(0.5 and 1 mg/kg, separated by 3 days). The regularity in cocaine
self-administration produced relatively stable serum cocaine
concentrations that oscillated between maximum
(Cmax) and minimum
(Cmin) values regardless of dose size and
interinfusion interval. Although the Cmax
for the 1-mg/kg unit dose (1.47 µg/ml) was significantly higher than
that for the 0.5-mg/kg dose (0.82 µg/ml), the
Cmin values between the groups approximated
each other (0.28, and 0.34 µg/ml, respectively). Hence, the
Cmin is the determinant of the initiation of
the next drug-taking behavior.
This article has been cited by other articles:
![]() |
A. B. Norman, M. R. Tabet, M. K. Norman, W. R. Buesing, A. J. Pesce, and W. J. Ball A Chimeric Human/Murine Anticocaine Monoclonal Antibody Inhibits the Distribution of Cocaine to the Brain in Mice J. Pharmacol. Exp. Ther., January 1, 2007; 320(1): 145 - 153. [Abstract] [Full Text] [PDF] |
||||